Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGSINE198H01019·Healthcare·www.aareydrugs.com ↗·Mcap ₹289 Cr·Listed 2021
₹101.57▲ ₹1.31  (1.31%)
52W: ₹50 – ₹104 · Vol: 1.1L shares · Close 25 Sept
Set Alert

Quarterly results

standalone · as filed with NSE · Q1 FY27 back to Q1 FY22
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22
Revenue from operations44.618996.484.210210813410512721076.557.85115862.576.311712014013597.5
Other income1.7−0.44.20.81.67.50.701.65.10.30.80.75.50.5−0.92.41.10.10.80.7
Total expenses45.818899.783.510211413310312721375.357.750.916262.27311911913813295.5
EBITDA1.34.3−1.52.61.7−4.92.23.71.2−1.42.71.81.3−2.21.54.3−0.61.93.13.42.9
EBITDA margin3.0%2.3%-1.6%3.1%1.7%-4.5%1.6%3.5%0.9%-0.7%3.5%3.2%2.6%-1.4%2.4%5.6%-0.5%1.5%2.2%2.5%3.0%
Finance costs1.71.80.91.312.50.91.511.21.11.30.910.70.60.50.60.50.60.5
Depreciation0.90.80.80.70.5−1.40.60.50.50.40.50.40.40.20.60.40.40.40.50.50.4
Profit before tax0.51.30.91.51.71.61.41.71.32.11.510.72.60.72.30.822.23.12.7
Tax−0.5−0.3−0.40.50.41.20.70.10.1−00.40.201.30.3−0.201.70.30.30.2
Net profit11.61.311.40.50.71.61.22.210.80.71.40.52.50.80.21.92.82.5
Net margin2.3%0.8%1.3%1.2%1.3%0.4%0.5%1.5%1.0%1.0%1.3%1.4%1.4%0.9%0.8%3.3%0.7%0.2%1.4%2.1%2.6%
EPS (₹)0.360.550.200.360.480.020.260.570.440.770.400.310.290.140.190.830.320.300.771.221.07
Net profit YoY−25.4%+231.3%+78.0%−35.9%+10.7%−78.2%−29.8%+103.5%+71.0%+58.9%+106.7%−69.0%−9.4%+495.0%−74.6%−11.1%−68.1%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22
Revenue from operations47247439662.5493
Other income6.19.870.52.7
Total expenses47347839762.2485
EBITDA7.22.34.51.511.3
EBITDA margin1.5%0.5%1.1%2.4%2.3%
Finance costs544.40.62
Depreciation2.91.91.70.72
Profit before tax5.46.15.30.710
Tax1.42.10.70.32.5
Net profit444.70.57.5
Net margin0.8%0.8%1.2%0.8%1.5%
EPS (₹)1.391.841.840.192.72
Net profit YoY−1.4%−14.1%+847.1%−93.4%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow10.19.77.9−39.118.6
Investing cash flow−12.4−5.9−7.311.124.4
Financing cash flow2.2−3.84.1−22.54.4
Capital expenditure12.4001−2.2
Free cash flow (CFO − capex)−2.39.77.9−40.116.4

Net profit trend

annual, ₹ crore
FY22
₹7.5
FY23
₹0.5−93%
FY24
₹4.7+847%
FY25
₹4−14%
FY26
₹4−1%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Standalone14 Aug 2026PDF on NSE XBRL
Q4 FY26Standalone · audited30 May 2026PDF on NSE XBRL
Q3 FY26Standalone–PDF on NSE XBRL
Q3 FY26Standalone11 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone–PDF on NSE XBRL
Q2 FY26Standalone14 Nov 2025PDF on NSE XBRL
Q1 FY26Standalone13 Aug 2025PDF on NSE XBRL
Q4 FY25Standalone · audited31 May 2025 PDF XBRL
Q3 FY25Standalone14 Feb 2025PDF on NSE XBRL
Q2 FY25Standalone14 Nov 2024PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 56.2×59.2×
P/B5Y avg 1.04×1.92×
ROEFY26, on average equity2.7%
Net margin0.8%
Debt / equity0.33×
Revenue CAGR (3Y)96.3%
Profit CAGR (3Y)100.2%
EPS (TTM)₹1.72
Market cap₹289 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
1.92×
vs 8-point avg 1.04× (+84%)
0.58× low1.04× avg1.92× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹297 Cr+25%
Net worth₹150 Cr+9%
Total borrowings₹50 Cr+43%
Cash & bank balances₹1 Cr−5%
Investments₹2 Cr
Inventories₹42 Cr−9%
Trade receivables₹130 Cr+0%
Trade payables₹82 Cr+51%
Change vs the same date a year earlier.
Shareholding 6 Aug 2026
%Aug 26Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Mar 24
Promoter42.7937.7137.7139.0644.8044.8044.8044.8045.4445.2845.2845.28
FII4.414.804.183.861.131.972.342.342.753.403.403.40
DII1.491.621.62–––0.000.000.000.000.000.00
Retail38.2741.6643.7145.3947.0146.6045.7944.8747.5744.5047.1447.14
Other public13.0414.2112.7811.697.066.637.077.994.246.824.184.18
13,480 shareholders · NSE shareholding pattern filings.